Zejula 300 Pill - green oval, 19mm
Generic Name: niraparib
Pill with imprint Zejula 300 is Green, Oval and has been identified as Zejula 300 mg. It is supplied by GlaxoSmithKline.
Zejula is used in the treatment of Ovarian Cancer; Fallopian Tube Cancer; Peritoneal Cancer and belongs to the drug class PARP inhibitors. Zejula 300 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for Zejula 300
Zejula
- Generic Name
- niraparib
- Imprint
- Zejula 300
- Strength
- 300 mg
- Color
- Green
- Size
- 19.00 mm
- Shape
- Oval
- Availability
- Prescription only
- Drug Class
- PARP inhibitors
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- GlaxoSmithKline
- National Drug Code (NDC)
- 00173-0915
More about Zejula (niraparib)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (56)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: PARP inhibitors
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
